{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:04:53Z","timestamp":1789769093471,"version":"4.0.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been linked to improved outcomes following total knee arthroplasty (TKA). However, it remains unclear whether the observed benefits are attributable to weight loss, glycemic control, or first-line type 2 diabetes mellitus (T2DM) medications such as metformin. This study aimed to evaluate the impact of perioperative GLP-1RA use on TKA outcomes in T2DM patients stratified by obesity status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The TriNetX Global Collaborative Network was queried using relevant Current Procedural Terminology and ICD-10 codes for metformin-treated T2DM patients aged 18 years or older undergoing primary TKA. Patients were divided into two groups based on obesity status and further stratified based on GLP-1RA use within three months of surgery. The groups were propensity matched (1:1) based on age, sex, body mass index (BMI), HbA1c, and comorbidities. Surgical outcomes, medical complications, and resource utilization were assessed at 90 days and 1 year. Surgical outcomes and revision rates were also assessed at two years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In obese patients (n = 8,170), GLP-1RA use was associated with notable reductions in postoperative anemia (odds ratio [OR] 0.714;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), acute kidney injury (OR 0.755;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.021), 90-day readmission (OR 0.776;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), emergency department (ED) visits (OR 0.836;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008), and aseptic loosening at two years (OR 0.498;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.037). These patients also demonstrated greater postoperative reductions in BMI and HbA1c. In nonobese patients (n = 1,328), GLP-1RA use was similarly associated with lower rates of 90-day readmission (OR 0.514;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004) and ED visits (OR 0.649;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.024), although no notable differences in other outcomes were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Among metformin-treated T2DM patients undergoing TKA, GLP-1RA use was associated with reduced resource utilization irrespective of obesity. However, additional reductions in medical complications and aseptic loosening were observed in the obese group, suggesting a potential synergistic effect between weight loss and glycemic control. These findings highlight the effectiveness of GLP-1RAs in optimizing high-risk candidates undergoing TKA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-00982","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T21:00:12Z","timestamp":1773176412000},"page":"e2795-e2805","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Impact of GLP-1 Receptor Agonist Use on Total Knee Arthroplasty Outcomes in Metformin-Treated Diabetic Patients With and Without Comorbid Obesity: A Propensity-Matched Analysis"],"prefix":"10.5435","volume":"34","author":[{"given":"Seungjun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mason T.","family":"Sellig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry H.","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7337-3321","authenticated-orcid":false,"given":"Graham S.","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"R1-20260918","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.arth.2005.04.023","article-title":"Obesity and perioperative morbidity in total hip and total knee arthroplasty patients","volume":"20","author":"Namba","year":"2005","journal-title":"J Arthroplasty"},{"key":"R2-20260918","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.2106\/JBJS.J.01935","article-title":"Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: A single-center analysis of 7181 primary hip and knee replacements for osteoarthritis","volume":"94","author":"J\u00e4msen","year":"2012","journal-title":"J Bone Joint Surg Am"},{"key":"R3-20260918","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1007\/s11999-016-5222-4","article-title":"Obesity epidemic: Is its impact on total joint arthroplasty underestimated? An analysis of national trends","volume":"475","author":"George","year":"2017","journal-title":"Clin Orthop Relat Res"},{"key":"R4-20260918","first-page":"1","article-title":"Prevalence of obesity among older adults in the United States, 2007-2010","author":"Fakhouri","year":"2012","journal-title":"NCHS Data Brief"},{"key":"R5-20260918","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.arth.2018.02.020","article-title":"Inadequate glycemic control is associated with increased surgical site infection in total joint arthroplasty: A systematic review and meta-analysis","volume":"33","author":"Shohat","year":"2018","journal-title":"J Arthroplasty"},{"key":"R6-20260918","doi-asserted-by":"crossref","first-page":"e0150866","DOI":"10.1371\/journal.pone.0150866","article-title":"Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: A systematic review and meta-analysis","volume":"11","author":"Kunutsor","year":"2016","journal-title":"PLoS One"},{"key":"R7-20260918","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11999-014-3668-9","article-title":"The John Insall Award: Morbid obesity independently impacts complications, mortality, and resource use after TKA","volume":"473","author":"D'Apuzzo","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"R8-20260918","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/15563316211030923","article-title":"Preoperative patient optimization in total joint arthroplasty-the paradigm shift from preoperative clearance: A narrative review","volume":"18","author":"MacMahon","year":"2022","journal-title":"HSS J"},{"key":"R9-20260918","first-page":"e22.00112","article-title":"Projections and epidemiology of primary hip and knee arthroplasty in medicare patients to 2040-2060","volume":"8","author":"Shichman","year":"2023","journal-title":"JB JS Open Access"},{"key":"R10-20260918","doi-asserted-by":"crossref","first-page":"1431292","DOI":"10.3389\/fendo.2024.1431292","article-title":"Mechanisms of action and therapeutic applications of GLP-1 and dual GIP\/GLP-1 receptor agonists","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol"},{"key":"R11-20260918","doi-asserted-by":"crossref","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes\u2014State-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"key":"R12-20260918","doi-asserted-by":"crossref","first-page":"101506","DOI":"10.1016\/j.artd.2024.101506","article-title":"Glucagon-like Peptide-1 receptor agonist use is not associated with increased complications after total knee arthroplasty in patients with type-2 diabetes","volume":"30","author":"Heo","year":"2024","journal-title":"Arthroplasty Today"},{"key":"R13-20260918","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.arth.2024.05.079","article-title":"Decreased risk of readmission and complications with preoperative GLP-1 analog use in patients undergoing primary total joint arthroplasty","volume":"39","author":"Buddhiraju","year":"2024","journal-title":"J Arthroplasty"},{"key":"R14-20260918","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.arth.2023.12.023","article-title":"Semaglutide use prior to total hip arthroplasty results in fewer postoperative prosthetic joint infections and readmissions","volume":"39","author":"Magruder","year":"2024","journal-title":"J Arthroplasty"},{"key":"R15-20260918","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2106\/JBJS.24.00468","article-title":"Glucagon-like peptide-1 receptor agonists decrease medical and surgical complications in morbidly Obese patients undergoing primary TKA","volume":"107","author":"Kim","year":"2025","journal-title":"J Bone Joint Surg Am"},{"key":"R16-20260918","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"R17-20260918","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: A review","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA"},{"key":"R18-20260918","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthroplasty"},{"key":"R19-20260918","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cmet.2016.02.005","article-title":"Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity","volume":"23","author":"Magkos","year":"2016","journal-title":"Cell Metab"},{"key":"R20-20260918","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"R22-20260918","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: Update to a position statement of the American Diabetes Association and the European Association for the study of diabetes","volume":"38","author":"Inzucchi","year":"2014","journal-title":"Diabetes Care"},{"key":"R23-20260918","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"Stein","year":"2005","journal-title":"Am J Med"},{"key":"R24-20260918","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2011.11.052","article-title":"Diabetes mellitus and thrombosis","volume":"129","author":"Vazzana","year":"2012","journal-title":"Thromb Res"},{"key":"R25-20260918","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1464-5491.2011.03498.x","article-title":"Risk of acute renal failure in patients with type 2 diabetes mellitus","volume":"29","author":"Girman","year":"2012","journal-title":"Diabet Med"},{"key":"R26-20260918","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/CCM.0000000000001398","article-title":"Obesity, acute kidney injury, and mortality in critical illness","volume":"44","author":"Danziger","year":"2016","journal-title":"Crit Care Med"},{"key":"R27-20260918","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/1573399052952587","article-title":"Anaemia in diabetes: An emerging complication of microvascular disease","volume":"1","author":"Thomas","year":"2005","journal-title":"Curr Diabetes Rev"},{"key":"R28-20260918","doi-asserted-by":"crossref","first-page":"1293926","DOI":"10.3389\/fcdhc.2023.1293926","article-title":"The benefits of GLP1 receptors in cardiovascular diseases","volume":"4","author":"Ferhatbegovi\u0107","year":"2023","journal-title":"Front Clin Diabetes Healthc"},{"key":"R29-20260918","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.arth.2015.06.057","article-title":"Increased aseptic tibial failures in patients with a BMI \u226535 and well-aligned total knee arthroplasties","volume":"30","author":"Abdel","year":"2015","journal-title":"J Arthroplasty"},{"key":"R30-20260918","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/art.21139","article-title":"Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis","volume":"52","author":"Messier","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R31-20260918","first-page":"S158","article-title":"Pharmacologic approaches to glycemic treatment: Standards of care in diabetes\u20142024","volume":"47","year":"2023","journal-title":"Diabetes Care"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-00982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:00:11Z","timestamp":1789768811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-00982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":30,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-00982","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"2025-08-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}